Related Experiment Video
Updated: May 26, 2026
07:40
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
A statistician's perspective on biomarkers in drug development
Martin Jenkins1, Aiden Flynn, Trevor Smart
1AstraZeneca UK Ltd., Alderley Park, Macclesfield, UK. martin.jenkins@astrazeneca.com
Pharmaceutical Statistics
|December 14, 2011
Summary
Statisticians are crucial for the appropriate use of biomarkers in drug development. Ensuring robust study design and analysis maximizes the value of biomarker data for personalized medicine and safety assessments.
Area of Science:
- Biostatistics
- Pharmaceutical Sciences
- Biomarker Discovery
Background:
- Biomarkers are vital in pharmaceutical research, influencing personalized medicine and safety evaluations.
- Effective utilization of biomarker data relies heavily on robust statistical methodologies.
- The increasing complexity of biomarkers necessitates rigorous statistical approaches.
Purpose of the Study:
- To outline the fundamental role of statisticians in biomarker development and application.
- To emphasize the importance of sound scientific arguments for biomarker claims (predictivity, surrogacy).
- To provide guidance for statisticians entering biomarker-focused research.
Main Methods:
- Ensuring appropriate study design to address specific research questions.
- Implementing statistical analyses that account for all sources of variability.
- Addressing challenges posed by multidimensional biomarkers and indirect outcome measures.
- Maintaining statistical best practice with scientific rigor and practical insight.
Main Results:
- Statistical expertise is essential for valid biomarker interpretation.
- Proper study design and analysis prevent erroneous claims of predictivity or surrogacy.
- Handling multiplicity and confounding factors is critical for robust conclusions.
Conclusions:
- Statisticians play a pivotal role in maximizing the value of biomarkers in drug discovery and development.
- Adherence to statistical best practices ensures the scientific integrity of biomarker-based research.
- This article serves as an introductory guide for statisticians in biomarker research.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Biostatistics: Overview
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Discrete variables are...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:19Overview of Biostatistics in Health Sciences
Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...